Thus, a pro-inflammatory response alone is insufficient for the control of infection, since patients with Mucocutaneous Leishmaniasis exhibit an exacerbated inflammatory response with reduced levels of the regulatory cytokine IL-10, yet they are unable achieve cure (Rodrigues et al., 2014). This evidence concerns the gene IL10 and infection.